Alzheimer's Disease And Dementia
In patients with mild Alzheimer's disease, solanezumab did not significantly reduce cognitive decline over time.
Positive beliefs about age may protect against dementia.
Depressive symptoms and apathy were independently associated with incident dementia in community-dwelling older adults.
In the United States, it is estimated that 15 million people will have clinical Alzheimer disease or mild cognitive impairment by 2060.
There is no significant risk of Alzheimer's disease or dementia for men getting androgen deprivation therapy.
Primary hyperparathyroidism may be linked to lower intracerebral vasomotor reactivity, which could lead to cognitive dysfunction.
Depressive symptoms and subjective memory complaint could be used as early detection markers of Alzheimer's disease.
Midlife vascular risk factors such as smoking, diabetes, and hypertension are linked to a higher risk for dementia.
People born in higher stroke mortality states seem to have more health issues including a higher risk of developing dementia.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- The Challenges of Identifying Biomarkers of Psychiatric Illness
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- FDA Approves Powerful New Opioid Despite Criticisms
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Updates in Borderline Personality Disorder: Your Questions Answered
- Violent Video Games Tied to Physical Aggression
- Shame Drives Suicidal Ideation Among Veterans With PTSD
- Long-term Healthy Diet Associated With Greater Hippocampal Volumes
- Perseris Now Available for the Treatment of Schizophrenia in Adults
- Noninvasive Brain Stimulation of Prefrontal Cortex in Trait Anxiety
- Peer Support Reduces Hospitalizations in People With Diabetes and Depression
- FDA to Ban Most Flavored Electronic Cigarettes
- Predictors of CBT Outcomes Identified in Youths With Anxiety Disorders